These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10608510)

  • 1. Enlargement of a lower pole calcium oxalate stone: a theoretical examination of the role of crystal nucleation, growth, and aggregation.
    Kavanagh JP
    J Endourol; 1999 Nov; 13(9):605-10. PubMed ID: 10608510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nidus, crystalluria and aggregation: key ingredients for stone enlargement.
    Saw NK; Rao PN; Kavanagh JP
    Urol Res; 2008 Feb; 36(1):11-5. PubMed ID: 18030459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer.
    Kavanagh JP; Nishio S; Garside J; Blacklock NJ
    J Urol; 1993 Mar; 149(3):614-7. PubMed ID: 8437278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human urine on aggregation of calcium oxalate crystals.
    Springmann KE; Drach GW; Gottung B; Randolph AD
    J Urol; 1986 Jan; 135(1):69-71. PubMed ID: 3941471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring calcium oxalate crystallization: a constant composition approach.
    Kolbach-Mandel AM; Kleinman JG; Wesson JA
    Urolithiasis; 2015 Oct; 43(5):397-409. PubMed ID: 26016572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine.
    Edyvane KA; Hibberd CM; Harnett RM; Marshall VR; Ryall RL
    Clin Chim Acta; 1987 Aug; 167(3):329-38. PubMed ID: 3621616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased calcium oxalate crystal nucleation and aggregation by peroxidized protein of human kidney stone matrix and renal cells.
    Govindaraj A; Selvam R
    Urol Res; 2001 Jun; 29(3):194-8. PubMed ID: 11482446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro.
    Atmani F; Khan SR
    BJU Int; 2000 Apr; 85(6):621-5. PubMed ID: 10759652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate.
    Khan SR
    J Urol; 1997 Jan; 157(1):376-83. PubMed ID: 8976301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlargement of calcium oxalate stones to clinically significant size in an in-vitro stone generator.
    Ananth K; Kavanagh JP; Walton RC; Rao PN
    BJU Int; 2002 Dec; 90(9):939-44. PubMed ID: 12460360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and stone formation inside the nephron.
    Kok DJ
    Scanning Microsc; 1996; 10(2):471-84; discussion 484-6. PubMed ID: 9813625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wu-Ling-San formula inhibits the crystallization of calcium oxalate in vitro.
    Chen YC; Ho CY; Chen LD; Hsu SF; Chen WC
    Am J Chin Med; 2007; 35(3):533-41. PubMed ID: 17597511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.